WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke BLUEROCK wurde als Wortmarke am 21.08.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1380110 |
| Länder | 
|
| Basismarke |
Nr. 87361159,
07. März 2017
|
| Anmeldedatum | 21. August 2017 |
| Ablaufdatum | 21. August 2027 |
Markeninhaber
1 Broadway, Floor 15
Cambridge MA 02142
US
Cambridge MA 02142
US
Markenvertreter
143 CadyCenter, Ste. 209
Northville MI 48167
US
Waren und Dienstleistungen
01
Chemical and biological preparations for industrial and
scientific use, namely, body cells and cells of the immune
system of mammals, including human cells; analytical kits
consisting of chemical reagents for industrial and
scientific use, for the purification, detection and
immobilization of body cells and cells of the immune system
of mammals, including human cells; diagnostic preparations
except for medical purposes; combinations of cells and
materials for biological use
05
Cells for medical or clinical use; kits comprised of cells
and pharmaceuticals for medical or clinical use;
therapeutics for the treatment of liver, hepatological,
cardiovascular, central nervous system, endocrine,
gastrointestinal, immunological, dermatological, infectious,
inflammatory, menopausal, metabolic, autoimmune,
musculoskeletal, neurological, ophthalmologic, psychiatric,
renal, aural, respiratory, sensory-neural, urogenital,
urological, hematologic, fungal and viral diseases and
disorders; pharmaceutical preparations for the treatment of
liver, hepatological, cardiovascular, central nervous
system, endocrine, gastrointestinal, immunological,
dermatological, infectious, inflammatory, menopausal,
metabolic, autoimmune, musculoskeletal, neurological,
ophthalmologic, psychiatric, renal, aural, respiratory,
sensory-neural, urogenital, urological, hematologic, fungal
and viral diseases and disorders; biological preparations
for the treatment of liver, hepatological, cardiovascular,
central nervous system, endocrine, gastrointestinal,
immunological, dermatological, infectious, inflammatory,
menopausal, metabolic, autoimmune, musculoskeletal,
neurological, ophthalmologic, psychiatric, renal, aural,
respiratory, sensory-neural, urogenital, urological,
hematologic, fungal and viral diseases and disorders; gene
therapy products, namely, therapeutics for the treatment of
liver, hepatological, cardiovascular, central nervous
system, endocrine, gastrointestinal, immunological,
dermatological, infectious, inflammatory, menopausal,
metabolic, autoimmune, musculoskeletal, neurological,
ophthalmologic, psychiatric, renal, aural, respiratory,
sensory-neural, urogenital, urological, hematologic, fungal
and viral diseases and disorders; chemical and biological
preparations for medical use, namely, body cells and cells
of the immune system of mammals, including human cells
40
Manufacturing services for others in the field of
pharmaceuticals
42
Scientific and industrial research in the field of
biochemistry, diagnostics or pharmaceuticals; biochemical or
pharmaceutical laboratory services, namely, cultivation and
purification of cells, namely, of body cells and cells of
the immune system of mammals including human cells;
pharmaceutical research and development; medical research,
namely, conducting clinical trials for others; providing
scientific and technological information about
investigational medical devices, diagnostics and drugs via a
website; research and development of human therapeutics
using gene editing
44
Providing medical information; providing medical information
via a website; providing medical information, consultancy
and advisory services; providing information relating to
diagnostic, prophylactic and therapeutic properties of
pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 03. August 2021 | 2021/35 Gaz | US | RAW: Partial Ceasing Effect |
| 18. März 2019 | 2019/12 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 07. Februar 2019 | 2019/7 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Dezember 2018 | 2019/8 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 08. August 2018 | 2018/37 Gaz | CN | Ablehnung |
| 26. Juli 2018 | 2018/30 Gaz | KR | Ablehnung |
| 26. Juli 2018 | 2018/31 Gaz | JP | Ablehnung |
| 23. Juli 2018 | 2018/30 Gaz | IN | Ablehnung |
| 18. Juli 2018 | 2018/29 Gaz | AU | Ablehnung |
| 07. März 2018 | 2018/11 Gaz | SG | Ablehnung |
| 21. August 2017 | 2017/48 Gaz | US | Eintragung |
ID: 141380110